Company
CAVOS
Advancing longevity therapies with cross-species validated natural variants
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
caVos identifies genetic variants conserved across long-lived species to develop first-in-class mRNA therapies validated by nature for efficacy and safety
Loading relationship preview